1-3 of 3
Pina M. Cardarelli, PhD.
Close
Sort by
Journal Articles

Novel CXCR4-Targeted Therapy to Inhibit Multiple Myeloma Bone Dissemination

Aldo M Roccaro, MD PhD, Antonio Sacco, BS, Michele Moschetta, MD, Yuji Mishima, PhD, Patricia Maiso, PhD, Daisy Huynh, MPS, Marco Chiarini, MSc, Pina M. Cardarelli, PhD, Lewis Cohen, MD MS, Michelle Kuhne, PhD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2014) 124 (21): 4709.
https://doi.org/10.1182/blood.V124.21.4709.4709
Published: 2014
Journal Articles

Phase Ib Study of the Novel Anti-CXCR4 Antibody Ulocuplumab (BMS-936564) in Combination with Lenalidomide Plus Low-Dose Dexamethasone, or with Bortezomib plus Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma

Irene M. Ghobrial, MD, Raymond Perez, MD, Rachid Baz, MD, Paul G. Richardson, Kenneth C. Anderson, MD, Peter Sabbatini, PhD, Clifford Dilea, Pina M. Cardarelli, PhD, Mark Wade, Guan Xing, PhD, Andres Gutierrez, MD PhD, Lewis Cohen, MD MS, Pamela S. Becker, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3483.
https://doi.org/10.1182/blood.V124.21.3483.3483
Published: 2014
Journal Articles

Characterization of MDX-1401, a Human Anti-CD30 Antibody with Enhanced Effector Function, for Therapy of Malignant Lymphoma.

Pina M. Cardarelli, PhD., Cristina Loomis, PhD., Ben Preston, Amelia Black, PhD., David Passmore, PhD., Tseng-Hui Chen, PhD., Sharline Chen, Jie Liu, PhD., Michelle R Kuhne, PhD, Mohan Srinivasan, PhD., Albert Assad, MD, Alison Witte, Marco Coccia, PhD, Robert F. Graziano, PhD., David J. King, PhD.
Journal: Blood
Blood (2008) 112 (11): 1580.
https://doi.org/10.1182/blood.V112.11.1580.1580
Published: 2008